ZEAL:CPH
Zealand Pharma
238,00 DKK
arrow_upward
+0,42%(+1,00) 1 D
9. okt., 17:00:00 GMT+2 · DKK
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for ZEAL …
Åpne
240,00 DKK
Høy
241,70 DKK
Lav
236,00 DKK
Markedsverdi
17,04 mrd.
Snittvolum
412,72k
Volum
293,77k
52 u høy
556,00 DKK
52 u lav
233,50 DKK
Utestående aksjer
71,61 mill.
Antall ansatte
578
Åpne
240,00 DKK
Høy
241,70 DKK
Lav
236,00 DKK
Markedsverdi
17,04 mrd.
Snittvolum
412,72k
Volum
293,77k
52 u høy
556,00 DKK
52 u lav
233,50 DKK
Utestående aksjer
71,61 mill.
Antall ansatte
578
Nyhetssaker
Fra nettkilder og nyhetspartnere
MedWatch
·
for 2 døgn siden
Zealand CEO still backs “crown jewel” petrelintide despite another share slide
Investing.com
·
for 3 døgn siden
Zealand Pharma falls 3% despite positive mid-stage obesity drug results
Profil
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Om Zealand Pharma
Administrerende direktørAdam Steensberg
Ansatte578
Grunnlagt1. apr. 1997
Hovedkontor-
Sektor-
Nettstedzealandpharma.com